Reference 1.80–2.59 | <1.40 | 1.40–1.79 | 2.60–2.99 | 3.00–4.89 | ≥4.90 | P interaction | |
(1) Age | |||||||
Cases/population, event rate (%) | 1445/103 217, 1.40 | 365/19 540, 1.87 | 450/25 925, 1.74 | 678/56 717, 1.20 | 1413/125 079, 1.13 | 169/13 789, 1.23 | 0.20 |
<65 years, OR (95% CI) | 1 | 1.21 (1.08 to 1.36) | 1.21 (1.09 to 1.35) | 0.87 (0.79 to 0.95) | 0.81 (0.75 to 0.87) | 0.74 (0.63 to 0.87) | |
Cases/population, event rate (%) | 2586/146 116, 1.77 | 765/31 451, 2.43 | 912/41 662, 2.19 | 1200/73 153, 1.64 | 2160/145 714, 1.48 | 206/16 097, 1.28 | |
≥65 years OR (95% CI) | 1 | 1.28 (1.18 to 1.39) | 1.22 (1.13 to 1.32) | 0.95 (0.88 to 1.02) | 0.85 (0.80 to 0.90) | 0.64 (0.56 to 0.74) | |
(2) Sex | |||||||
Cases/population, event rate (%) | 2548/163 555, 1.56 | 736/34 102, 2.16 | 883/45 454, 1.94 | 1126/82 239, 1.37 | 1980/157 999, 1.25 | 215/16 451, 1.31 | 0.70 |
Men, OR (95% CI) | 1 | 1.26 (1.16 to 1.37) | 1.21 (1.12 to 1.31) | 0.90 (0.84 to 0.96) | 0.82 (0.77 to 0.87) | 0.72 (0.63 to 0.83) | |
Cases/population, event rate (%) | 1483/85 778, 1.73 | 394/16 889, 2.33 | 479/22 133, 2.16 | 752/47 631, 1.58 | 1593/112 794, 1.41 | 160/13 435, 1.19 | |
Women, OR (95% CI) | 1 | 1.25 (1.11 to 1.40) | 1.23 (1.11 to 1.37) | 0.94 (0.86 to 1.03) | 0.85 (0.78 to 0.91) | 0.64 (0.54 to 0.75) | |
(3) Body mass index | |||||||
Cases/population, event rate (%) | 2977/176 545, 1.69 | 833/36 815, 2.26 | 1036/48 736, 2.13 | 1334/89 252, 1.49 | 2456/181 432, 1.35 | 262/20 396, 1.28 | 0.40 |
<25 kg/m2, OR (95% CI) | 1 | 1.23 (1.14 to 1.33) | 1.23 (1.15 to 1.33) | 0.91 (0.85 to 0.97) | 0.82 (0.77 to 0.86) | 0.67 (0.59 to 0.76) | |
Cases/population, event rate (%) | 1054/72 788, 1.45 | 297/14 176, 2.10 | 326/18 851, 1.73 | 544/40 618, 1.34 | 1117/89 361, 1.25 | 113/9490, 1.19 | |
≥25 kg/m2, OR (95% CI) | 1 | 1.34 (1.17 to 1.52) | 1.17 (1.03 to 1.32) | 0.93 (0.84 to 1.04) | 0.86 (0.79 to 0.94) | 0.72 (0.59 to 0.87) | |
(4) Thrombolysis treatment | |||||||
Cases/population, event rate (%) | 675/15 139 | 160/3099 | 177/3861 | 284/8134 | 541/16 494 | 46/1452 | 0.04 |
With thrombolysis treatment, OR (95% CI) | 1 | 1.01 (0.84 to 1.21) | 0.96 (0.81 to 1.14) | 0.81 (0.70 to 0.94) | 0.79 (0.70 to 0.89) | 0.63 (0.46 to 0.85) | |
Cases/population, event rate (%) | 3356/234 198 | 970/47 892 | 1185/63 726 | 1594/121 736 | 3032/254 299 | 329/28 434 | |
Without thrombolysis treatment, OR (95% CI) | 1 | 1.30 (1.21 to 1.40) | 1.26 (1.18 to 1.35) | 0.94 (0.88 to 0.99) | 0.84 (0.80 to 0.88) | 0.69 (0.62 to 0.78) |
Adjusted for age, sex, smoking, alcohol intake, National Institutes of Health Stroke Scale (NIHSS) (0–4; 5–15; 16–20; 21–42; missing data of NIHSS); medical history (hypertension; diabetes mellitus); history of anticoagulation; dual antiplatelet therapy; systolic blood pressure (per 20 mm Hg); fasting glucose; intravenous thrombolytic therapy; body mass index, kg/m2 (<18.5, 18.5–25, 25–30, ≥30).